Cambridge International Systems Awarded Defense Healthcare Management System Modernization Program Subcontract

As a team member for the Leidos Partnership for Defense Health, Cambridge International Systems (Cambridge) is pleased to be part of the team that has been awarded a contract by the Department of Defense (DoD) to provide an electronic health record off-the-shelf solution, integration activities and deployment across the Military Health System. The contract, known as the Defense Healthcare Management System Modernization (DHMSM), is an initiative designed to modernize the military’s healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for those who serve and have served our country and their families.

Modernizing the medical records of the millions of service members and their families is vitally important to DoD and our nation. DHMSM will continue the DoD’s leadership in utilizing the best healthcare technology, and can help improve medical outcomes and support the medical readiness of the U.S. military.

“Cambridge is proud to be part of the Leidos Partnership for Defense Health, the team that has been selected as the best value solution for the DHMSM contract,” said Dr. Kim Harokopus, Cambridge CEO. “Together, our qualified and experienced team is prepared to lean forward with the Department of Defense to deliver a world class electronic health records solution for our nation’s armed forces, their families and beneficiaries. We look forward to the work ahead and are committed to improving healthcare and providing important decision support capabilities to facilitate improved clinical outcomes for our deserving men and women in uniform.”

In Cambridge’s role with the Leidos Partnership, we look forward working with our outstanding team of 22 small business partners, 8 large business partners, 4 Core Partners, and 17 Technology Vendors and Suppliers on the mission ahead to achieve DHMSM success.

The $4.3 billion indefinite-delivery/indefinite-quantity contract has a two-year initial ordering period, with two 3-year option periods, and a two-year award term which is earned through successful performance during the previous contract periods.